The RNA Cooperative is a small group of emerging market vaccine manufacturers and global nonprofit organizations working together to advance RNA vaccine development and manufacturing. The Cooperative fosters innovation and capacity building and supports multiple vaccine targets to build a foundation for broader regional impact and sustainable vaccine production. 

RNA vaccine technology is a flexible vaccine development approach able to rapidly generate safe and efficacious vaccines at large scale, but the technology has largely been inaccessible to low- and middle-income country vaccine manufacturers. During the COVID-19 pandemic, lower income countries were last in line to receive new vaccines and had vaccination rates that trailed far behind those of higher-income countries once they did—illustrating the importance of establishing RNA vaccine manufacturing to ensure equitable vaccine access at the local, regional, and global levels.